Pharma stocks are grabbing attention due to strong healthcare demand, rising global medicine need and increasing exports.

Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

Could this be the secret to Pfizer's rebound strategy?

Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China sent ...

Mike Rogers worked for pharmaceutical companies. He was never a registered lobbyist, and there’s no proof he received $14 million to lobby for the pharmaceutical industry. Michigan U.S. Senate ...

Neurocrine Biosciences, Inc. stays a Buy as Ingrezza, Crenessity, and Vykat drive 44% revenue growth; see valuation, patents ...

David Meek bought the company last year for the pharma industry equivalent of loose change. The company was on the brink of ...

Proven to help stroke patients regain use of their limbs, an implant is the focus of a new center at UConn Health.

The seven companies listed here cover the realistic range of what a buyer will encounter in 2026: embedded ML teams that own ...

Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, ...

On June 4, Goldman Sachs analyst Richard Law reiterated a Buy rating on the stock and assigned a target price of $42. Earlier ...